antiparasitic drug treatment ivermectin A study by Malaysian researchers has shown that COVID-19 did not prevent patients from becoming seriously ill.
In the study, published in the journal JAMA Internal Medicine, the researchers said their findings do not support the use of ivermectin for patients with COVID-19.
The study enrolled 490 patients with mild to moderate illness in 20 hospitals and a COVID-19 quarantine center in Malaysia. all received standard care; Half the group also received ivermectin.
Serious illness developed in 21.6% of patients with ivermectin and 17.3% of patients who received only standard care, the researchers said. He defined severe illness as the need for oxygen to help him breathe.
According to the study, there was no statistically significant difference between the groups in the rate of ICU admission, mechanical ventilation needed or death.
The researchers said that doctors and patients all knew which group the patients were assigned to, and that such an “open-label” trial design may have introduced bias, potentially underestimating the drug’s effect. can go.
The use of ivermectin to treat COVID-19 is currently being investigated in a UK trial run by the University of Oxford. The researchers have said they do not wish to comment until they have results to report.
With inputs from agencies.
Never miss a story! Stay connected and informed with Mint.
download
Our App Now!!
,